← Leaderboards
Malik Bisserier
New York Medical College
$405,909
Attributed
$405,909
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $135.3K · FY2022–24$200K$150K$100K$50K$0
'22
'23
'24
Funding mix
By agency
NIH$405,909 · 1
By mechanism
K01$405,909 · 1
Top collaborators
No co-investigators on record.
Most similar at New York Medical College
Same institution · by research overlap
- Pravin B Sehgal$4,451,684
- Jason Edward Lee$1,647,934
Others in their field
Other Rising Stars on “Failure”
- Suma Babu · Massachusetts General Hospital$11,004,714
- Sabrina Paganoni · Massachusetts General Hospital$11,004,714
- Jennifer Lee O'Brien · University Of South Florida$10,506,386
- April Carson · University Of Mississippi Med Ctr$9,022,104
- Frank A Provenzano · St. Joseph'S Hospital And Medical Center$8,533,907
- Hong-Ngoc B. Nguyen · University Of Minnesota$6,812,121
Research focus
FailureFunctional DisorderAnimal ModelAffectBinding SitesArteriesBone LossBone Morphogenetic Protein ReceptorsBone Morphogenetic ProteinsBindingCellsCell TypeCessation Of LifeBlood VesselsDistalDna MethylationDna ReceptorEndothelial CellsEndothelial DysfunctionEndotheliumEnhancersEpigenetic ProcessEpigenetic RegulationGene Expression
Grant awards (3)
Role of SIN3a in the epigenetic regulation of the Bone Morphogenetic Protein Receptor Type 2 in pulmonary arterial hypertension$135,303
K01 · FY2024 · HL · contact PI
Role of SIN3a in the epigenetic regulation of the Bone Morphogenetic Protein Receptor Type 2 in pulmonary arterial hypertension$135,303
K01 · FY2023 · HL · contact PI
Role of SIN3a in the epigenetic regulation of the Bone Morphogenetic Protein Receptor Type 2 in pulmonary arterial hypertension$135,303
K01 · FY2022 · HL · contact PI